stella
beta
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK) — Stella
Home
/
Breast Cancer
/
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
View on ClinicalTrials.gov
Recruiting
Back to Breast Cancer trials
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
Trial locations
(1 site)
Canada
Princess Margaret Hospital, Toronto, Ontario